GACM
INFI

Green Arrow Capital Management’s Infinity Pharmaceuticals, Inc. INFI Stock Holding History

Green Arrow Capital Management’s Portfolio INFI Stock Details INFI Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2014
Q4 		– Sell
-75,000
Closed -$1.01M – 177
2014
Q3 		$1.01M Buy
+75,000
New +$893K 0.08% 146

Other funds holding INFI

O
OrbiMed New York $5.05B AUM 125.28% 1-Year Est. Return
DM
Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.14% 1-Year Est. Return
BB
BB Biotech Schaffhausen, Switzerland $3.98B AUM 15.47% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.26% 1-Year Est. Return

Green Arrow Capital Management's INFI Position: Q4 2014 in Review

Green Arrow Capital Management sold out of Infinity Pharmaceuticals, Inc. (INFI) in Q4 2014, closing a stake of 75,000 shares — an estimated $1.01M sold.

Green Arrow Capital Management first reported a position in INFI in Q3 2014 and held it in 1 quarter. The position peaked at $1.01M in Q3 2014. 143 funds tracked by Wall St. Rank hold INFI as of Q4 2014.

  • Green Arrow Capital Management reported no remaining Infinity Pharmaceuticals, Inc. position as of Q4 2014 after selling out during the quarter.
  • Green Arrow Capital Management sold 75,000 Infinity Pharmaceuticals, Inc. shares in Q4 2014, an estimated $1.01M.
  • Green Arrow Capital Management first reported a position in Infinity Pharmaceuticals, Inc. in Q3 2014 and held it in 1 quarter.
  • Green Arrow Capital Management's Infinity Pharmaceuticals, Inc. position peaked at $1.01M in Q3 2014.
  • 143 funds tracked by Wall St. Rank held Infinity Pharmaceuticals, Inc. as of Q4 2014.

Based on Green Arrow Capital Management's 13F filing for Q4 2014, filed 17 Feb 2015.